Article
2017 Clinical trials update in new treatments of β‐thalassemia
9 Aug 2016
Abstract excerpt
The underlying basis of β-thalassemia pathology is the diminished β-globin synthesis leading to α-globin accumulation and premature apoptotic destruction of erythroblasts, causing oxidative stress-induced ineffective erythropoiesis, bone marrow hyperplasia, splenomegaly, and increased intestinal iron absorption with progressive iron overload. Better understanding of the molecular mechanisms underlying this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
